Vivici
PrivateLast Round
Grant
Jun 17, 2026
Total Funding Raised
$48.1M
Company Overview
Vivici is a biotechnology company that produces animal-free dairy proteins using precision fermentation for food and nutrition applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Sustainable Materials, Sports & Fitness
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vivici Comparables
Compare Vivici with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Verley | 87% | |
| Imagindairy | 84% | |
| TurtleTree | 83% |
Vivici Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 17, 2026 | ||||
| Series A | Feb 25, 2025 | ||||
| Seed | Aug 14, 2023 |
Key People
Founding team and executive leadership
Vivici Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| Invest-NL | Series A |
| APG Asset Management | Series A |
| DSM Venturing | Seed |
| InnovationQuarter | Series A |
| DSM-Firmenich Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 3, 2025
Collaborated with Abu Dhabi Investment Office on alternative protein production.
- Nov 3, 2025
Partnering to advance alternative protein production using fermentation in the UAE.
Recent news
Latest coverage and updates
- partners_withOct 17, 2026
Vivici secures a manufacturing partnership with Liberation Labs to produce its Vivitein(TM) beta-lactoglobulin protein ingredient at a new Indiana facility, with commercial-scale output expected in 2026.
Vivici Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Vivici's valuation, stock price, and market status.
Is Vivici a public or private company?
Vivici is a private company.
What is the current stock price of Vivici?
Vivici is a private company, so its shares have no public market price. Caplight tracks Vivici's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Vivici worth (valuation)?
Valuation information for Vivici is not publicly available.
Can I buy Vivici stock?
Vivici shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Vivici's last funding round?
Vivici's most recent funding round was Grant on June 17, 2026.
Who are the main investors in Vivici?
Key investors in Vivici include European Innovation Council Fund, Invest-NL, APG Asset Management.
Will Vivici IPO soon?
No public IPO plans have been announced for Vivici.
How can I track Vivici secondary market activity?
Caplight tracks bids, offers, and trades in Vivici's shares on secondary markets.